These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


125 related items for PubMed ID: 9817597

  • 1. Pituitary-directed leukemia inhibitory factor transgene causes Cushing's syndrome: neuro-immune-endocrine modulation of pituitary development.
    Yano H, Readhead C, Nakashima M, Ren SG, Melmed S.
    Mol Endocrinol; 1998 Nov; 12(11):1708-20. PubMed ID: 9817597
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pituitary corticotroph SOCS-3: novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion.
    Auernhammer CJ, Chesnokova V, Bousquet C, Melmed S.
    Mol Endocrinol; 1998 Jul; 12(7):954-61. PubMed ID: 9658400
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Leukemia inhibitory factor (LIF) stimulates proopiomelanocortin (POMC) expression in a corticotroph cell line. Role of STAT pathway.
    Ray DW, Ren SG, Melmed S.
    J Clin Invest; 1996 Apr 15; 97(8):1852-9. PubMed ID: 8621768
    [Abstract] [Full Text] [Related]

  • 7. Hypothalamic and pituitary leukemia inhibitory factor gene expression in vivo: a novel endotoxin-inducible neuro-endocrine interface.
    Wang Z, Ren SG, Melmed S.
    Endocrinology; 1996 Jul 15; 137(7):2947-53. PubMed ID: 8770918
    [Abstract] [Full Text] [Related]

  • 8. Disrupted murine leukemia inhibitory factor (LIF) gene attenuates adrenocorticotropic hormone (ACTH) secretion.
    Akita S, Malkin J, Melmed S.
    Endocrinology; 1996 Jul 15; 137(7):3140-3. PubMed ID: 8770940
    [Abstract] [Full Text] [Related]

  • 9. Human and murine pituitary expression of leukemia inhibitory factor. Novel intrapituitary regulation of adrenocorticotropin hormone synthesis and secretion.
    Akita S, Webster J, Ren SG, Takino H, Said J, Zand O, Melmed S.
    J Clin Invest; 1995 Mar 15; 95(3):1288-98. PubMed ID: 7883977
    [Abstract] [Full Text] [Related]

  • 10. Opposing effects of pituitary leukemia inhibitory factor and SOCS-3 on the ACTH axis response to inflammation.
    Chesnokova V, Kariagina A, Melmed S.
    Am J Physiol Endocrinol Metab; 2002 May 15; 282(5):E1110-8. PubMed ID: 11934677
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Leukemia inhibitory factor mediates the hypothalamic pituitary adrenal axis response to inflammation.
    Chesnokova V, Melmed S.
    Endocrinology; 2000 Nov 15; 141(11):4032-40. PubMed ID: 11089533
    [Abstract] [Full Text] [Related]

  • 13. cAMP neuropeptide agonists induce pituitary suppressor of cytokine signaling-3: novel negative feedback mechanism for corticotroph cytokine action.
    Bousquet C, Chesnokova V, Kariagina A, Ferrand A, Melmed S.
    Mol Endocrinol; 2001 Nov 15; 15(11):1880-90. PubMed ID: 11682619
    [Abstract] [Full Text] [Related]

  • 14. Cell-specific pituitary gene expression profiles after treatment with leukemia inhibitory factor reveal novel modulators for proopiomelanocortin expression.
    Abbud RA, Kelleher R, Melmed S.
    Endocrinology; 2004 Feb 15; 145(2):867-80. PubMed ID: 14576184
    [Abstract] [Full Text] [Related]

  • 15. Leukemia inhibitory factor (LIF) modulates pro-opiomelanocortin (POMC) gene regulation in stably transfected AtT-20 cells overexpressing LIF.
    Li QL, Yano H, Ren SG, Li X, Friedman TC, Melmed S.
    Endocrine; 1997 Dec 15; 7(3):325-30. PubMed ID: 9657069
    [Abstract] [Full Text] [Related]

  • 16. Direct regulation of pituitary proopiomelanocortin by STAT3 provides a novel mechanism for immuno-neuroendocrine interfacing.
    Bousquet C, Zatelli MC, Melmed S.
    J Clin Invest; 2000 Dec 15; 106(11):1417-25. PubMed ID: 11104795
    [Abstract] [Full Text] [Related]

  • 17. A common pro-opiomelanocortin-binding element mediates leukemia inhibitory factor and corticotropin-releasing hormone transcriptional synergy.
    Bousquet C, Ray DW, Melmed S.
    J Biol Chem; 1997 Apr 18; 272(16):10551-7. PubMed ID: 9099700
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-11 stimulates proopiomelanocortin gene expression and adrenocorticotropin secretion in corticotroph cells: evidence for a redundant cytokine network in the hypothalamo-pituitary-adrenal axis.
    Auernhammer CJ, Melmed S.
    Endocrinology; 1999 Apr 18; 140(4):1559-66. PubMed ID: 10098488
    [Abstract] [Full Text] [Related]

  • 19. Leukemia inhibitory factor induces differentiation of pituitary corticotroph function: an immuno-neuroendocrine phenotypic switch.
    Stefana B, Ray DW, Melmed S.
    Proc Natl Acad Sci U S A; 1996 Oct 29; 93(22):12502-6. PubMed ID: 8901611
    [Abstract] [Full Text] [Related]

  • 20. Leukemia inhibitory factor regulates prolactin secretion in prolactinoma and lactotroph cells.
    Ben-Shlomo A, Miklovsky I, Ren SG, Yong WH, Heaney AP, Culler MD, Melmed S.
    J Clin Endocrinol Metab; 2003 Feb 29; 88(2):858-63. PubMed ID: 12574225
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.